NO20006631L - Forbindelser oppnådd fra salvie-arter med antiviral aktivitet - Google Patents

Forbindelser oppnådd fra salvie-arter med antiviral aktivitet

Info

Publication number
NO20006631L
NO20006631L NO20006631A NO20006631A NO20006631L NO 20006631 L NO20006631 L NO 20006631L NO 20006631 A NO20006631 A NO 20006631A NO 20006631 A NO20006631 A NO 20006631A NO 20006631 L NO20006631 L NO 20006631L
Authority
NO
Norway
Prior art keywords
tetramers
trimers
antiviral activity
compounds obtained
groups
Prior art date
Application number
NO20006631A
Other languages
English (en)
Norwegian (no)
Other versions
NO20006631D0 (no
Inventor
Myun K Han
Paul Lee
Original Assignee
Univ Georgetown
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Georgetown filed Critical Univ Georgetown
Publication of NO20006631D0 publication Critical patent/NO20006631D0/no
Publication of NO20006631L publication Critical patent/NO20006631L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F246/00—Copolymers in which the nature of only the monomers in minority is defined
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20006631A 1998-06-25 2000-12-22 Forbindelser oppnådd fra salvie-arter med antiviral aktivitet NO20006631L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/104,363 US6037369A (en) 1998-06-25 1998-06-25 Compounds obtained from salvia species having antiviral Activity
PCT/US1999/014297 WO1999066942A1 (en) 1998-06-25 1999-06-25 Compounds obtained from salvia species having antiviral activity

Publications (2)

Publication Number Publication Date
NO20006631D0 NO20006631D0 (no) 2000-12-22
NO20006631L true NO20006631L (no) 2001-02-26

Family

ID=22300096

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006631A NO20006631L (no) 1998-06-25 2000-12-22 Forbindelser oppnådd fra salvie-arter med antiviral aktivitet

Country Status (18)

Country Link
US (1) US6037369A (xx)
EP (1) EP1089747A1 (xx)
JP (1) JP2002518455A (xx)
KR (1) KR20010071580A (xx)
CN (1) CN1312722A (xx)
AU (1) AU740698B2 (xx)
BR (1) BR9912218A (xx)
CA (1) CA2335956A1 (xx)
CZ (1) CZ20004858A3 (xx)
HU (1) HUP0103398A2 (xx)
ID (1) ID28792A (xx)
IL (1) IL140483A0 (xx)
IS (1) IS5792A (xx)
MX (1) MXPA01000195A (xx)
NO (1) NO20006631L (xx)
PL (1) PL345086A1 (xx)
TR (1) TR200100450T2 (xx)
WO (1) WO1999066942A1 (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001505583A (ja) * 1996-12-05 2001-04-24 ジョージタウン ユニヴァーシティー 抗ウイルス活性を有するサルビア種の抽出物
US6043276A (en) * 1998-06-25 2000-03-28 Georgetown University School Of Medicine Compounds obtained from salvia species having antiviral activity
WO2001085189A1 (de) * 2000-05-05 2001-11-15 Parsenn-Produkte Ag Zubereitung zur topischen behandlung von durch virusinfektionen verursachten manifestationen
SG98409A1 (en) * 2000-06-21 2003-09-19 Chi Chiang Yang Pharmaceutical compositions and combinations for the treatment or prophylaxis of disorders related to hiv and retrovirus
JP2002020283A (ja) * 2000-06-22 2002-01-23 Yang Chi-Chiang Ｈｉｖおよびレトロウイルスに関連する障害の処置または予防のための薬学的組成物および組み合わせ
KR20020005222A (ko) * 2000-06-28 2002-01-17 치-치앙 양 Ｈｉｖ 또는 레트로바이러스에 관련된 질환의 치료 또는예방용 약학적 조성물 및 조합물
US7071227B2 (en) * 2000-09-26 2006-07-04 The Johns Hopkins University Antiviral compositions and methods of use
US20070027209A1 (en) * 2005-08-01 2007-02-01 Lee Hyun C Prevention and treatment of atherosclerosis with lithospermate B
WO2008117901A1 (en) * 2007-03-28 2008-10-02 Industry-Academic Cooperation Foundation, Yonsei University A method for isolation of high concentration of magnesium lithospermate b from salviae miltiorrhizae
US20120041062A1 (en) * 2009-03-30 2012-02-16 Tianjin Tasly Pharmaceutical Co., Ltd. Compound of salvianolic acid l, preparation method and use thereof
CN101919836A (zh) * 2009-06-17 2010-12-22 山东绿叶天然药物研究开发有限公司 迷迭香酸的新用途
CN103054976B (zh) * 2011-10-21 2014-09-24 上海中医药大学 一种治疗血小板减少症的中药组合物及其制备方法和应用
CN103845403B (zh) * 2014-02-27 2016-10-05 河南大学 丹参配方颗粒在制备预防和治疗艾滋病脑病药物方面的应用
CN104974119B (zh) * 2014-04-01 2018-10-19 中国科学院上海药物研究所 一种高纯度丹酚酸b镁及其制备方法
CN108042524A (zh) * 2017-12-21 2018-05-18 南方医科大学 丹酚酸b及其结构类似物在制备抗hpv病毒感染药物中的应用
CN109771410B (zh) * 2019-03-06 2020-11-24 湖北大学 紫草酸在制备抗乙肝病毒药物中的用途
CN109771407B (zh) * 2019-03-29 2021-11-26 成都医学院 迷迭香酸在制备抑制水痘-带状疱疹病毒的药物中的用途
CN110922286B (zh) * 2019-11-23 2022-08-16 上海化工研究院有限公司 一种非对称芳基取代富烯化合物及其制备方法与应用
JPWO2021221043A1 (xx) * 2020-04-30 2021-11-04
CN114712342B (zh) * 2022-05-10 2023-04-21 湖北大学 紫草酸在制备抗流感病毒药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5178865A (en) * 1990-06-19 1993-01-12 Cedars-Sinai Medical Center Chinese herbal extracts in the treatment of hiv related disease in vitro
US5346695A (en) * 1991-03-27 1994-09-13 Tampa Bay Research Institute Methods of inhibiting HIV replication in vitro using polymers of p-hydroxylated cinnamic acids
JP2001505583A (ja) * 1996-12-05 2001-04-24 ジョージタウン ユニヴァーシティー 抗ウイルス活性を有するサルビア種の抽出物

Also Published As

Publication number Publication date
CN1312722A (zh) 2001-09-12
WO1999066942A9 (en) 2000-06-22
AU740698B2 (en) 2001-11-15
CZ20004858A3 (cs) 2001-09-12
NO20006631D0 (no) 2000-12-22
TR200100450T2 (tr) 2001-07-23
CA2335956A1 (en) 1999-12-29
PL345086A1 (en) 2001-12-03
MXPA01000195A (es) 2002-04-24
IS5792A (is) 2000-12-22
BR9912218A (pt) 2002-07-23
EP1089747A1 (en) 2001-04-11
KR20010071580A (ko) 2001-07-28
ID28792A (id) 2001-07-05
JP2002518455A (ja) 2002-06-25
IL140483A0 (en) 2002-02-10
HUP0103398A2 (hu) 2002-01-28
US6037369A (en) 2000-03-14
WO1999066942A1 (en) 1999-12-29
AU4714999A (en) 2000-01-10

Similar Documents

Publication Publication Date Title
NO20006631L (no) Forbindelser oppnådd fra salvie-arter med antiviral aktivitet
CY1106178T1 (el) 2’- υποκατεστημενα 1,1’-διφαινυλο-2-καρβοξαμιδια, μεθοδος για την παρασκευη τους, η χρηση τους ως φαρμακου καθως και φαρμακευτικα παρασκευασματα που τα πepιεχουν
ATE218582T1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen
BG103969A (en) C-4"-substituted macrolide derivatives
MXPA01006917A (es) Composicion topica que comprende n-acetilaldosaminas o acidos n-acetilaminos.
ATE218580T1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen
AU2905092A (en) Pharmaceutical dipeptide compositions and methods of use thereof
BR0015911A (pt) Derivados de benzoimidazole úteis como agentes antiproliferativos
TWI256950B (en) Indanyl-substituted benzenecarboxamides, processes for their preparation, their use as a medicament and pharmaceutical formulations containing them
BR0000003A (pt) Azalidas e métodos de preparação das mesmas
MX9205937A (es) Sistema de penetracion incrementada de la piel para surtido topico mejorado de farmacos
DE69829175D1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zubereitungen
WO2001024816A3 (en) Compositions and methods relating to the inhibition of casomorphin and gluteomorphin
ES2002140A6 (es) Procedimiento para producir preparados de derivados de acido arilpropionico resorbibles por via transdermal y acuosos
KR960700062A (ko) 산성 pH에서의 안정성을 개선시키기 위해 변형된 올리고누클레오티드(OLIGONUCLEOTIDES MODIFIED TO IMPROVE STABILITY AT ACIC pH)
RU94022743A (ru) Амидо- или карбамидо-производные, обладающие антигиперхолестериновой активностью, и фармацевтическая композиция на их основе
BR9813319A (pt) Composto, composição farmacêutica para tratamento de infecções bacterianas, e, processos para tratar infecções bacterianas e para preparar um composto
BR9813317A (pt) Composto, composição farmacêutica para tratar infecções bacterianas, e, processos para tratar infecções bacterianas, e para preparar um composto
DK0862634T3 (da) Farmaceutisk præparat mod papillomavirustumorer og -infektioner
CA2390558A1 (en) Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and agents containing the same
EP0992509A3 (en) Novel macrolide derivatives
DE69500618D1 (de) Oligonukleotide mit wirkung gegen das respiratorische synzytial virus
FR2794976B1 (fr) Compositions pharmaceutiques a action cicatrisante ou anti-complementaire comprenant un derive de dextrane
FR2768145B1 (fr) Nouveaux composes derives d'acide alkylene diamine di- ou tri-acetique, leur procede de preparation, leur utilisation dans des compositions cosmetiques et pharmaceutiques, et compositions les comprenant
BR0008863A (pt) Processo para a preparação de ciclo(asp-dphe-nmeval-arg-gly)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application